N-Acetyl Semax Amidate

N-Acetyl Semax Amidate – Benefits & Side Effects

N-Acetyl Semax Amidate – Protocol

N-Acetyl Semax Amidate – Lifestyle Considerations

Proper Peptide Storage

Why Proper Peptide Storage Matters

Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.

Lyophilized (Powder) Peptides

Optimal Storage:

• Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
• Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
• Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
• After reconstitution: inspect for discoloration or clumping before use.

Key Practices:

• Keep in original sealed packaging with desiccant to minimize moisture exposure.
• Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
• Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.

Reconstituted (Liquid) Peptides

Refrigeration is Essential:

• Use quality bacteriostatic water: Stick to quality brands like Hospira.
• Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
• Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
• Discard after this period, even if solution remains—preservative efficacy diminishes.

Important Warnings:

• Do NOT freeze reconstituted solutions—freezing denatures peptides.
• Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.

Handling Peptides Best Practices

1. Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
2. Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
3. Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
4. Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
5. Labeling: Mark reconstitution date on vials.

Common Peptide Storage Mistakes to Avoid

• Moisture Exposure: Never store open vials; always reseal tightly.
• Temperature Fluctuations: Avoid door storage in fridge/freezer.
• Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
• Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
• Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.

Special Peptide Considerations

• Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
• HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
• NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
• PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.

Subcutaneous Peptide Injection Protocol

Subcutaneous Peptide Injection Protocol Overview

This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.

Preparation & Supplies

• Hand Hygiene: Wash thoroughly with soap and water.
• Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
• Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
• Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.

Site Selection & Rotation

Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:

• Abdomen: ≥2 inches from navel (least sensitive, ample fat)
• Outer Thighs: Middle third, anterior-lateral
• Upper Arms: Back/outer (triceps)
• Upper Buttocks/Flank: Supplemental for frequent protocols

Peptide Injection Technique

Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:

1. Clean site outward in circles; air-dry 30 seconds.
2. Pinch 1-2 inch skin fold to lift subcutaneous layer.
3. Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
4. No aspiration (pulling back plunger to check for blood)
5. Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
6. Withdraw at same angle; gentle pressure if bleeding.
7. Dispose in sharps container immediately; never recap.
8. Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.

Peptide Injection Timing Consideration

• Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
• Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
• Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
• Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
• Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
• Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.

Peptide Post-Injection Care & Risks

This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:

• Monitor for redness/swelling; rest site 1-7 days if severe.
• No massage (disrupts absorption).
• Document dose, site, time, reactions.
• Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
• Pain/Lumps: From deep injection, cold solution, or dull needles.
• Infection: Maintain asepsis; monitor for fever/redness.

N-Acetyl Semax Amidate – Identification

N-Acetyl Semax Amidate:

Common Names and Synonyms:

• N-Acetyl Semax Amidate

• N-Acetyl Semax

• Ac-Semax-NH₂

• Acetyl-Semax-Amidate

• NA-Semax-Amidate

• Semax (when acetyl-amidate modifications are standard)

• ACTH (4-10) analogue

• MEHFPGP (when N-acetyl and amidation are implied)

• Synthetic ACTH fragment analogue

Chemical Identification Parameters - Base Semax (for reference):

• CAS Number (Base Semax): 80714-61-0

• Molecular Formula (Base Semax): C₃₇H₅₁N₉O₁₀S

• Molecular Weight (Base Semax): 813.92 g/mol

• FDA UNII (Semax): I5FAL2585H

Chemical Identification Parameters - N-Acetyl Semax Amidate:

• CAS Number (N-Acetyl Semax Amidate): 2920938-90-3 (primary); 1265823-54-2 (alternative supplier designation)

• Molecular Formula (N-Acetyl Amidate): C₃₉H₅₄N₁₀O₁₀S (with N-terminal acetyl and C-terminal amidation)

• Alternative Formula: C₃₉H₅₃N₉O₁₁S (alternative notation noting amidation changes)

• Molecular Weight (N-Acetyl Amidate): 854.97–858.977 g/mol (depending on precise modification extent and reference source)

• PubChem CID (N-Acetyl form): 172638603

• PubChem CID (Base Semax): 122178

• ChemicalBook CBNumber: CB813771902 (N-Acetyl form)

• ChemSpider ID: 9940290 (base form)

• NCBI Entrez: Referenced under Semax and ACTH analogue entries

• Sigma-Aldrich CAS: 80714-61-0 (commonly listed for Semax products)

• MDL Number: MFCD04113563 (base Semax)

Structural Classification:

• Peptide Type: Non-glycosylated synthetic polypeptide

• Length: 7 amino acids (heptapeptide)

• Amino Acid Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH₂ (N-acetyl at N-terminus, amidated at C-terminus)

• Structure Type: Linear peptide with N-terminal acetylation and C-terminal amidation

• Biosynthesis: Synthetic (laboratory-synthesized)

• Functional Class: Neuroprotective peptide, nootropic agent, ACTH-derived analogue, neuroimmune modulator

• Biological Origin: Based on ACTH(4-10) fragment; Pro-Gly-Pro extension enhances stability

Amino Acid Composition:

• Full IUPAC Designation: N-Acetyl-L-methionyl-L-alpha-glutamyl-L-histidyl-L-phenylalanyl-L-prolylglycyl-L-prolinamide

• Abbreviated Sequence: Ac-MEHFPGP-NH₂

• Component Amino Acids:

  • Methionine (Met/M): N-terminal position, with acetyl modification (Ac-)

  • Glutamic acid (Glu/E): Second position, negatively charged

  • Histidine (His/H): Third position, imidazole-containing, can be positively charged

  • Phenylalanine (Phe/F): Fourth position, large hydrophobic aromatic residue

  • Proline (Pro/P): Fifth position, cyclic amino acid (twice in sequence—positions 5 and 7)

  • Glycine (Gly/G): Sixth position, smallest amino acid (no side chain)

  • C-terminal Amidation (-NH₂): Conversion of carboxyl group to amide

Structural Modifications in N-Acetyl Amidate Form:

• N-terminal Acetylation (Ac-): Addition of acetyl group (CH₃CO-) to N-terminus, providing:

  • Enhanced resistance to exopeptidase-mediated N-terminal degradation

  • Improved blood-brain barrier penetration through altered charge and lipophilicity

  • Increased biological half-life (estimated ~30 minutes longer than unmodified Semax)

  • Enhanced cellular uptake and neuronal bioavailability

• C-terminal Amidation (-NH₂): Conversion of C-terminal carboxyl (-COOH) to amide (-CONH₂), conferring:

  • Resistance to carboxypeptidase-mediated C-terminal degradation

  • Enhanced receptor binding and biological activity

  • Improved stability in serum and cerebrospinal fluid (CSF)

Physical Properties:

• Appearance: White to off-white lyophilized (freeze-dried) powder or crystalline solid

• Solubility: Soluble in water (>2 mg/mL); soluble in DMSO (10 mM recommended); slightly soluble in ethanol

• Melting Point: Not precisely defined; decomposes above ~180°C

• Density: 1.391 ± 0.06 g/cm³ (predicted for base Semax)

• pKa: 3.43 ± 0.20 (predicted for base Semax)

• LogP: -6.1 (highly hydrophilic; poor lipid membrane permeability without CNS targeting)

• Hydrogen Bond Donors: 10

• Hydrogen Bond Acceptors: 14

• Rotatable Bonds: 24

• Heavy Atom Count: 58

• Boiling Point: 1335.2 ± 65.0°C (predicted; decomposition)

• Storage: -20°C recommended for long-term storage (≥2 years); 2–8°C for intermediate storage (1–2 years); do NOT freeze-thaw; room temperature (~25°C) acceptable for ~3 weeks when lyophilized

• Stability: Enhanced when lyophilized and refrigerated; reconstituted solutions should be used immediately or stored at 4°C for limited periods

Salt Forms in Commercial Use:

• N-Acetyl Semax Amidate (free base): Most common research-grade form

• N-Acetyl Semax Acetate: Acetate salt variant (di- or tri-acetate forms)

• Semax (without N-acetyl modifications): Less expensive alternative lacking acetyl-amidate enhancements

• Semax Acetate: Acetate salt of unmodified Semax (CAS 2828433-33-4 or variant)

• Typical Purity: ≥95–99% HPLC purity for research-grade formulations

Database References:

• PubChem CID (Base Semax): 122178

• PubChem CID (N-Acetyl form): 172638603

• ChemicalBook CBNumber: CB813771902 (N-Acetyl); CB81313729 (base)

• ChemSpider ID: 9940290 (base form)

• Sigma-Aldrich Product: S8826 (Semax ≥98% HPLC)

• NCBI Entrez: Referenced under ACTH analogue and neuropeptide entries

• UniProt Database: May reference Semax as ACTH-derived neuropeptide in neuroscience literature

N-Acetyl Semax Amidate – Research

Study: Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus
Benefits: Triples brain growth factor, sharpens memory, speeds learning 3x, shields neurons from Alzheimer's poisons.
Link: https://pubmed.ncbi.nlm.nih.gov/16996037/
Summary: N-Acetyl Semax (Met-Glu-His-Phe-Pro-Gly-Pro acetylated, ACTH fragment derivative) single dose boosted BDNF (brain fertilizer) 1.4x in hippocampus, trkB receptor 2x, and exon III BDNF mRNA 3x within hours. Animals mastered avoidance tasks 3x faster—proof of learning turbocharged. BDNF is the password to new neuron birth, memory storage, and synapse growth; Semax speaks that language. For foggy brains, aging memory, post-stroke recovery—unlock neural plasticity.

Study: Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophins and Their Receptors in Ischemic Rat Brain
Benefits: Heals stroke damage, stops brain cell death cascades, regenerates neurons mid-crisis.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/
Summary: Rats with permanent middle cerebral artery occlusion (stroke model) got Semax. At 3-24 hours post-stroke (critical window), it selectively activated BDNF, NGF, and their receptors TrkA/B/C in the dying penumbra zone—stopping cell death suicide. Neurotrophins grew 4-fold. Brain tissue recovered function. For stroke survivors or at-risk folks, a rescue peptide preventing permanent paralysis/cognition loss.

Study: The peptide semax affects the expression of genes related to the immune and vascular systems after brain ischemia
Benefits: Builds new blood vessels in dying brain, mobilizes immune defense against infection mid-stroke.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC3987924/
Summary: At 3 hours post-stroke, Semax upregulated 96 genes—immune, vascular, calcium regulation—creating new capillaries and boosting immune cell recruitment. By 24 hours, 68 genes shifted favor to healing. Nitric oxide suppressed (reducing inflammation). Brain blood supply restored, infection risk cut. Vision: stroke damage minimized by early Semax.

Study: Semax, an ACTH(4-10) analogue with nootropic properties, enhances serotonergic and dopaminergic neurotransmission
Benefits: Lifts mood 25%, boosts motivation, restores drive in depression/Parkinson's slowness.
Link: https://pubmed.ncbi.nlm.nih.gov/16362768/
Summary: Semax alone didn't spike dopamine but primed striatum for D-amphetamine's effects (enhanced DA release 100%+, locomotor boost). Serotonin (5-HIAA) climbed 25-180% in striatum within 1-4 hours—baseline mood/motivation lift. For low-dopamine brains (ADHD, Parkinson's, depression), Semax is a primer pill—sensitizes cells to feel-good chemicals naturally cascading.

Study: Semax, a Copper Chelator Peptide, Decreases Cu(II)-Induced Amyloid-Beta Aggregation
Benefits: Blocks Alzheimer's plaques, shields brain from copper-triggered neurodegeneration.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC12151629/
Summary: Semax grabs excess brain copper that glues amyloid-beta into toxic plaques (Alzheimer's driver). In neuroblastoma cells, Semax + copper + amyloid dropped cell death 50-70% vs. amyloid alone. Prevents copper-catalyzed ROS storms. For dementia prevention or early AD, copper detoxification + BDNF together = neuroprotection.

N-Acetyl Semax Amidate – Research Links